Phase II Avastin Trial for Stage IIIB/IV NSCLC

Clinical trial NCT00766246 · TERMINATED

Trial details

NCT number: NCT00766246
Sponsor: Pharmatech
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV

Start date: 2008-10-01
Primary completion: 2012-04-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.